Xeltis
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
31 De Lismortel, Eindhoven, North Braban...Phone Number
+31 407517614Website
www.xeltis.comRevenue
$10 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Xeltis
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis' restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs and it currently has operations in The Netherlands and in the USA. Xeltis' investors include venture capital funds Kurma Partners, LSP, VI Partners and Ysios Capital as well as a number of private investors. CAUTION: The Xeltis technology is an investigational device and NOT approved for sale. 1Morales DL, Herrington C, Bacha EA, Morell VO, Prodán Z, Mroczek T, Sivalingam S, Cox M, Bennink G and Asch FM (2021) A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials.Explore more
Xeltis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xeltis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Xeltis
Check if Xeltis has recently received funding, and reach out quickly before it becomes old news!
Click to see if Xeltis had a recent Job posting/layoffs
Earning: See what the market has to say on Xeltis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Xeltis is spiking on competitors!
Product Launch: Get notified when Xeltis launches new products
Funding: Get notified immidiatlly once Xeltis has new funding data
Xeltis, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Xeltis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xeltis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xeltis.
Xeltis financials insights
Gather financial insights about Xeltis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series B
$3.3M
2017
Series C
$52.8M
2023
Series D
$34M
Xeltis Tech Stack
A closer look at the technologies used by Xeltis
Most Recent Scoops
Open Position
Funding
Funding
Left Company
Executive Move
Promotion
Promotion
Xeltis News & Media
Over half of target patients enrolled in Xeltis’ aXess US pivotal trial
The company plans to enrol a total of 140 patients in the trial of the aXess device.Xeltis exceeds 50% enrollment in US Pivotal trial for aXess™, its vascular access device for hemodialysis
Xeltis announces that it has exceeded 50% enrollment in its US pivotal trial for aXess™Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment
Xeltis announces new 12 month clinical data from the aXess multi-center EU pivotal trialXeltis receives CE mark for aXess™, its aXess hemodialysis conduit™, as it moves to commercialization
Xeltis announces that it has received CE mark for aXess™
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xeltis
Sign Up For FreeTo access detailed company insights
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis' restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access. Xeltis was formed through the merger... Read More
